Vivani Medical, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Vivani Medical, Inc. on September 23, 2022. The report serves to disclose non-public information regarding upcoming investment conference presentations in compliance with Regulation FD.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of presentation materials rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the distribution of presentation materials to investors.
Guidance, Outlook, and Management Commentary
- Event: Management, including CEO Adam Mendelsohn, CFO Brigid Makes, and Chief Business Officer Don Dwyer, will present at investment conferences.
- Materials: A slide deck (Exhibit 99.1) is attached and incorporated by reference.
- Disclaimer: The presentation materials speak as of September 23, 2022. The company explicitly disclaims any obligation to update these materials or reflect future events.
- Legal Status: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Presentation Materials) for specific operational updates and strategic outlook.
- Verify the date of the presentation materials to ensure no subsequent events have occurred that may alter the context.
- Confirm that the presentation materials are not considered "filed" for liability purposes under Section 18 of the Exchange Act.
- Check for subsequent filings (e.g., 10-Q or 10-K) for actual financial performance data, as this 8-K contains no financial figures.